 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/05/2026 |
$61.10 |
$61.66 |
$58.85 |
$61.26 |
2.34M | | 01/06/2026 |
$61.09 |
$64.89 |
$61.02 |
$64.60 |
2.44M | | 01/07/2026 |
$65.46 |
$66.59 |
$64.46 |
$65.42 |
2.46M | | 01/08/2026 |
$65.35 |
$65.90 |
$62.05 |
$63.32 |
1.50M | | 01/09/2026 |
$64.10 |
$64.98 |
$62.28 |
$62.51 |
2.48M |
|
|
| Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. Co. specializes in muscle biology and the mechanics of muscle performance. It is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. Its cardiac muscle contractility program is focused on the cardiac sarcomere. | |
|
Cytokinetics (CYTK) has the following price history information. Looking back at CYTK historical stock prices for the last five trading days, on January 05, 2026, CYTK opened at $61.10, traded as high as $61.66 and as low as $58.85, and closed at $61.26. Trading volume was a total of 2.34M shares. On January 06, 2026, CYTK opened at $61.09, traded as high as $64.89 and as low as $61.02, and closed at $64.60. Trading volume was a total of 2.44M shares. On January 07, 2026, CYTK opened at $65.46, traded as high as $66.59 and as low as $64.46, and closed at $65.42. Trading volume was a total of 2.46M shares. On January 08, 2026, CYTK opened at $65.35, traded as high as $65.90 and as low as $62.05, and closed at $63.32. Trading volume was a total of 1.50M shares. On January 09, 2026, CYTK opened at $64.10, traded as high as $64.98 and as low as $62.28, and closed at $62.51. Trading volume was a total of 2.48M shares.
CYTK Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cytokinetics shares, starting with a $10,000 purchase of CYTK, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/13/2016 |
|
| End date: |
01/09/2026 |
|
| Start price/share: |
$8.82 |
|
| End price/share: |
$62.51 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
608.73% |
|
| Average Annual Total Return: |
21.64% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$70,881.19 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 01/05/2026 | $61.26 | | 01/06/2026 | $64.60 | | 01/07/2026 | $65.42 | | 01/08/2026 | $63.32 | | 01/09/2026 | $62.51 |
|
|
Free CYTK Email Alerts:
